Evidence map›Paper›PMID 29295527›Full record

ArticleInternational journal of molecular sciences2017

Characterizing Metastatic

Laura Caggiari, Gianmaria Miolo, Angela Buonadonna, Debora Basile, Davide A Santeufemia, Antonio Cossu, Giuseppe Palmieri, Mariangela De Zorzi, Mara Fornasarig, Lara Alessandrini and 6 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Cancers · 2022
    Article
  4. PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus-related diseases.Liver international : official journal of the International Association for the Study of the Liver · 2021
    Article
  5. Article
  6. Family's History Based on theInternational journal of molecular sciences · 2020
    Article
  7. Review
  8. Molecular Features Distinguish Gastric Cancer Subtypes.International journal of molecular sciences · 2018
    Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Laura CaggiariImmunopathology and Cancer Biomarkers, IRCCS CRO National Cancer Institute, 33081 Aviano, Italy. lcaggiari@cro.it.
Gianmaria MioloMedical Oncology, IRCCS, CRO National Cancer Institute, 33081 Aviano, Italy. gmiolo@cro.it.
Angela BuonadonnaMedical Oncology, IRCCS, CRO National Cancer Institute, 33081 Aviano, Italy. abuonadonna@cro.it.
Debora BasileMedical Oncology, IRCCS, CRO National Cancer Institute, 33081 Aviano, Italy. deborabasile1090@gmail.com.
Davide A SanteufemiaSSD Oncology, Ospedale Civile Alghero, 07041 Alghero, Italy. davidesanteufemia@gmail.com.
Antonio CossuOperative Unit of Pathology Department of Surgical, Microsurgical and Medical Sciences, University of Sassari, 07100 Sassari, Italy. cossu@uniss.it.ORCID 0000-0002-2390-2205
Giuseppe PalmieriInstitute of Biomolecular Chemistry, Cancer Genetics Unit, C.N.R., 07100 Sassari, Italy. g.palmieri@icb.cnr.it.ORCID 0000-0002-4350-2276
Mariangela De ZorziImmunopathology and Cancer Biomarkers, IRCCS CRO National Cancer Institute, 33081 Aviano, Italy. mdezorzi@cro.it.
Mara FornasarigGastroenterology, IRCCS CRO National Cancer Institute, 33081 Aviano, Italy. mfornasarig@cro.it.
Lara AlessandriniPathology, IRCCS CRO National Cancer Institute, 33081 Aviano, Italy. lara.alessandrini@cro.it.
Vincenzo CanzonieriPathology, IRCCS CRO National Cancer Institute, 33081 Aviano, Italy. vcanzonieri@cro.it.ORCID 0000-0001-6010-0976
Giovanni Lo ReMedical Oncology Department, Santa Maria degli Angeli Hospital, 33170 Pordenone, Italy. Giovanni.lore@aopn.fvg.it.
Fabio PuglisiMedical Oncology, IRCCS, CRO National Cancer Institute, 33081 Aviano, Italy. fabio.puglisi@cro.it.ORCID 0000-0003-0573-4938
Agostino SteffanImmunopathology and Cancer Biomarkers, IRCCS CRO National Cancer Institute, 33081 Aviano, Italy. asteffan@cro.it.
Renato CannizzaroGastroenterology, IRCCS CRO National Cancer Institute, 33081 Aviano, Italy. rcannizzaro@cro.it.
Valli De ReImmunopathology and Cancer Biomarkers, IRCCS CRO National Cancer Institute, 33081 Aviano, Italy. vdere@cro.it.ORCID 0000-0001-6100-9373
Centro di Riferimento Oncologico · ITUniversity of Udine · ITAzienda Ospedaliera Santa Maria Degli Angeli · ITUniversity of Sassari · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The

Indexed as

AdultAgedAntigens, CDBase SequenceCadherinsErb-b2 Receptor Tyrosine KinasesFemaleGene FrequencyGerm-Line MutationHaplotypesHumansMaleMiddle AgedNeoplasm MetastasisProportional Hazards ModelsStomach NeoplasmsAntigens, CDCadherinsCDH1 protein, humanERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesCDH1E-cadherinHER2metastatic gastric cancerrs16260rs1801552

Identifiers

PMID29295527
PMCPMC5795997
OpenAlexW2780186926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.